Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
Persistence of leukemic stem cells (LSC) after chemotherapy is thought to be responsible for relapse and prevents the curative treatment of acute myeloid leukemia (AML) patients. LSC and normal hematopoietic stem cells (HSC) share many characteristics and co-exist in the bone marrow of AML patients....
Enregistré dans:
Auteurs principaux: | Gerrit J Schuurhuis, Michael H Meel, Floris Wouters, Lisa A Min, Monique Terwijn, Nick A de Jonge, Angele Kelder, Alexander N Snel, Sonja Zweegman, Gert J Ossenkoppele, Linda Smit |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/afdfbec2f3a140adb7a2c8c49ec3e1ce |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
par: Meaghan Boileau, et autres
Publié: (2019) -
Suppression of Transposable Elements in Leukemic Stem Cells
par: Anthony R. Colombo, et autres
Publié: (2017) -
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
par: Lars Velten, et autres
Publié: (2021) -
Hematopoietic stem cell transplantation
par: Eleftheria Hatzimichael, et autres
Publié: (2010) -
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
par: Donata Backhaus, et autres
Publié: (2021)